Lung cancer: a brief review of epidemiology and screening

• Type: Article in International Scientific Journal
• Date: 2018

Authors

Gouvinhas, C (Author) Other; De Mello, RA (Author) Other; Oliveira, D (Author) Other; Castro Lopes, JM (Author) Other; Castelo Branco, P (Author) Other; dos Santos, RS (Author) Other; Hespanhol, V (Author) Other; Daniel Pozza (Author) FMUP

Journal

Title: Future Oncology

Vol. 14

Pages: 567-575

ISSN: 1479-6694

Publisher: Future Medicine Ltd.

Indexing

ISI Web of Knowledge - 19 Citations

Scopus - 20 Citations

Scientific classification

CORDIS: Health sciences

FOS: Medical and Health sciences

Other information

Authenticus ID: P-00N-QED

DOI: 10.2217/fon-2017-0486

Abstract (EN): The global burden of lung cancer has been increasing over the past years, and is still a major threat to public health worldwide, leading to disabilities and premature mortality. Despite multifactorial cause, smoking remains as the major etiological factor, followed by occupational exposure to carcinogens, genetic predisposition and other concomitant diseases. In order to reduce the individual and social burden due to the direct and indirect costs related to the lung cancer treatment, accurate methods of screening are needed. Among those, x-ray with cytological analysis of sputum was first proposed. Nowadays, more sensitive methods such as low-dose computed tomography are being used to improve the early detection. In the future, molecular biomarkers may complement low-dose computed tomography and improve the robustness of early lung cancer detection.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 9